[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"skin-hydration\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:skin-hydration":29},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,2,0,[8,44],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":4,"eligibilityCriteria":15,"healthyVolunteers":16,"sex":17,"minAge":18,"maxAge":19,"enrollmentInfo":20,"targetDuration":4,"studyType":23,"phases":24,"briefSummary":26,"conditions":27,"keywords":4,"overallStatus":31,"whyStopped":4,"lastUpdateSubmitDate":32,"lastUpdatePostDateStruct":33,"startDateStruct":36,"completionDateStruct":38,"leadSponsor":40,"locationsCount":43},"100635110","study-of-a-peptide-creams-effect-on-the-facial-skin-barrier-using-a-side-by-side-comparison-100635110",false,"NCT07548424","Study of a Peptide Cream's Effect on the Facial Skin Barrier Using a Side-by-Side Comparison","Evaluation of the Effect of a Topical Formulation Containing Acetyl Hexapeptide-37 on Objective Skin Barrier Parameters of the Face in a Randomized Controlled Split-Face Design","Inclusion Criteria:\n\n* healthy volunteers who gave written informed consent\n\nExclusion Criteria:\n\n* presence of active skin diseases or dermatological conditions\n* known allergy or hypersensitivity to any ingredient of the study products\n* pregnancy or breastfeeding\n* use of topical or systemic corticosteroids, immunosuppressive drugs, or antihistamines prior to or during the study",true,"ALL","18 Years","50 Years",{"count":21,"type":22},30,"ESTIMATED","INTERVENTIONAL",[25],"NA","The goal of this clinical trial is to evaluate whether a topical face cream containing the peptide Acetyl Hexapeptide-37 improves skin hydration and strengthens the skin barrier compared to a placebo cream in healthy adult participants. The study uses a split-face design, in which one side of the face is treated with the peptide cream and the other side with a placebo (a cream without the active ingredient).\n\nThe main questions it aims to answer are:\n\n* Does the peptide cream improve skin hydration and reduce transepidermal water loss compared to placebo?\n* Does the peptide cream affect skin erythema or cause irritation?\n* How do participants rate the comfort and tolerability of the peptide cream?\n\nResearchers will compare the treated and placebo sides of the face to assess differences in skin barrier function and tolerability.\n\nParticipants will:\n\n* Attend a baseline visit for assessment of facial skin parameters, including hydration, transepidermal water loss, and erythema\n* Apply the peptide cream to one side of the face and the placebo cream to the other side once daily for 4 weeks\n* Attend weekly follow-up visits for non-invasive skin measurements\n* Record any skin sensations (e.g., stinging, tightness) or adverse effects throughout the study",[28,29,30],"Skin Barrier Function","Skin Hydration","Topical Peptide Effects on Facial Skin Barrier Function","RECRUITING","2026-06-15",{"date":34,"type":35},"2026-06-17","ACTUAL",{"date":37,"type":35},"2026-05-04",{"date":39,"type":22},"2027-01",{"name":41,"class":42},"University of Split, School of Medicine","OTHER",1,{"id":45,"slug":46,"hasResults":11,"nctId":47,"briefTitle":48,"officialTitle":48,"acronym":49,"eligibilityCriteria":50,"healthyVolunteers":16,"sex":17,"minAge":51,"maxAge":52,"enrollmentInfo":53,"targetDuration":4,"studyType":23,"phases":55,"briefSummary":56,"conditions":57,"keywords":4,"overallStatus":59,"whyStopped":4,"lastUpdateSubmitDate":60,"lastUpdatePostDateStruct":61,"startDateStruct":63,"completionDateStruct":65,"leadSponsor":67,"locationsCount":43},"100611142","evaluation-of-spm-topical-cosmetic-application-on-skin-appearance-hydration-and-barrier-support-in-healthy-adults-100611142","NCT07236736","Evaluation of SPM™ Topical Cosmetic Application on Skin Appearance, Hydration, and Barrier Support in Healthy Adults","SPMT","Inclusion Criteria:\n\n1. Generally healthy with no systemic or active dermatologic diseases.\n2. Willing and able to apply topical product daily for 6 weeks.\n3. Able to provide written informed consent.\n4. Willing to undergo skin biopsies and follow study procedures.\n\nExclusion Criteria:\n\n1. History of skin cancer or other malignancy within the past 10 years.\n2. Active or chronic dermatologic conditions (e.g., eczema, psoriasis, acne, rosacea).\n3. Known allergy or sensitivity to components of the investigational product.\n4. Current use of systemic corticosteroids or immunosuppressants.\n5. Pregnancy or breastfeeding.\n6. Any condition that, in the investigator's opinion, would interfere with study participation or pose additional risk.","20 Years","75 Years",{"count":54,"type":22},10,[25],"This is an exploratory, cosmetic-use study evaluating the effects of Super Protein Multifunction (SPM™), a topical peptide-based formulation, on skin appearance, hydration, and barrier-related characteristics in healthy adults. The study aims to collect preliminary biophysical and histologic data on cosmetic skin changes following six weeks of SPM™ use. Participants will apply the product to a designated skin area while a matched contralateral area serves as the untreated comparison site. Skin hydration, transepidermal water loss (TEWL), and tissue markers of skin structure and barrier integrity will be assessed before and after product use. The study includes noninvasive measurements and small punch biopsies at two timepoints.",[58,29],"Healthy Skin","NOT_YET_RECRUITING","2025-12-17",{"date":62,"type":35},"2025-12-19",{"date":64,"type":22},"2026-01-30",{"date":66,"type":22},"2027-06-30",{"name":68,"class":69},"Biocoz Global Pte. Ltd.","INDUSTRY"]